
BIO-key International fell 76.2% from $8.83 to $2.10, behind the S&P 500's +4.7%. Its worst day was May 12 (−34.8%), and its low came Oct 12 at $1.65.
Nov 21, 2025 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
BIO-key International shares rose 34.1%, while the S&P 500 fell 0.0%.
+34.1% · S&P 500 0.0%
Story events cover the past 12 months · Times ET
EPS of $-1.90 missed the $-0.70 estimate on $1.2M revenue (est. $2.2M).
−11.4% · S&P 500 +2.9%
BIO-key International shares fell 34.8%, while the S&P 500 fell 0.2%.
−34.8%, the year's worst day · S&P 500 −0.2%
EPS of $-0.15 beat the $-0.60 estimate on $2.1M revenue (est. $2.2M); Q2 revenue guidance of $2.8M against the $2.2M consensus.
+31.5% · S&P 500 0.0%
Trading of BIO-key’s shares was restored following a June 16th hearing with a Nasdaq Hearings Panel, in which the Panel determined the Company has regained compliance with the continued listing standards, including
+43.4% · S&P 500 −0.5%
EPS of $-0.56 beat the $-0.82 estimate on $1.9M revenue (est. $1.8M).
−15.6% · S&P 500 −0.2%
BIO-key International shares rose 85.7%, while the S&P 500 fell 0.2%.
+85.7%, the year's best day, on 170M shares, the year's heaviest volume · S&P 500 −0.2%
BIO-key International closed at its lowest level of the year, 81.3% below where the year started.
−1.2% · S&P 500 −0.1%
BIO-key International shares rose 30.5%, while the S&P 500 fell 1.2%.
+30.5% · S&P 500 −1.2%
EPS of $-4.01 missed the $-0.35 estimate on $1.5M revenue (est. $2.4M).
−17.8% · S&P 500 −0.4%
Where it ended: a close of $2.10 on Nov 19, 2026.
Nothing in the past 12 months.
All BKYI analyst actionsNothing in the past 12 months.
All BKYI dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BKYI and SPY from Benzinga historical bars. Not investment advice.